Bonglip Tablet 50mg
Bonglip Tablet 50mg is a medicine used to treat type 2 diabetes mellitus. It is used together with a healthy diet and regular exercise to control blood sugar levels. This helps to prevent serious complications of diabetes like kidney damage and blindness.
Bonglip Tablet 50mg
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Bonglip Tablet 50mg is a medicine used to treat type 2 diabetes mellitus. It is used together with a healthy diet and regular exercise to control blood sugar levels. This helps to prevent serious complications of diabetes like kidney damage and blindness.
Bonglip Tablet 50mg is a medicine used to treat type 2 diabetes mellitus. It is used together with a healthy diet and regular exercise to control blood sugar levels. This helps to prevent serious complications of diabetes like kidney damage and blindness.
Bonglip Tablet 50mg is normally prescribed when diet and exercise alone or other medicines do not prove sufficient to control your blood sugar level. Your doctor may prescribe it alone or along with other diabetes medicines. It may be taken on an empty stomach or with a meal. The dose will depend on your condition and blood sugar levels. Therefore, you should use it as advised by your doctor.
You should take it regularly at the same time each day to get the most benefit, and you should not stop unless your doctor recommends it. This medicine helps you to control your blood sugar levels and prevent serious complications in the future. It is important to stay on the diet and exercise program recommended by your doctor while taking this medicine. Your lifestyle plays a big part in controlling diabetes.
The most common side effect of taking this medicine is a headache. This is usually minor and improves with time. Low blood sugar level (hypoglycemia) is a possible side effect if you are also taking other diabetes medicines like insulin or sulfonylurea, so you need to know how to recognize and deal with it. It may also cause upper respiratory tract infections like a sore throat, cough, and cold. Contact your doctor if the side effects worry you or if they do not go away.
Before taking this medicine, let your doctor know if you have ever had kidney disease, heart or pancreas problems, or if you drink a lot of alcohol. Pregnant or breastfeeding women should also consult their doctor before taking it. Some other medicines you are taking may interfere with this medicine. So, make sure your doctor knows about all the other medicines you are using. Limit your alcohol intake while taking this medicine because it can increase your risk of developing low blood sugar levels. You may need regular tests, such as kidney function and blood glucose levels, to check that the medicine is working properly.
03Uses
Type 2 diabetes mellitus
04How To Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Bonglip Tablet 50mg may be taken with or without food, but it is better to take it at a fixed time.
05How It Works
Bonglip Tablet 50mg is an antidiabetic medication. It works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces the fasting and post-meal sugar levels.
06What If You Miss A Dose?
Q: What if you forget to take Bonglip Tablet?
A: If you miss a dose of Bonglip Tablet 50mg, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
07Side Effects
Nasopharyngitis (inflammation of the throat and nasal passages)
Headache
Hypoglycemia (low blood glucose level)
08Safety Information
Alcohol:UNSAFE
It is unsafe to consume alcohol with Bonglip Tablet 50mg.
Pregnancy:CONSULT YOUR DOCTOR
Information regarding the use of Bonglip Tablet 50mg during pregnancy is not available. Please consult your doctor.
Breast feeding:CONSULT YOUR DOCTOR
Bonglip Tablet 50mg is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving:CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Kidney:CAUTION
Bonglip Tablet 50mg should be used with caution in patients with severe kidney disease. Dose adjustment of Bonglip Tablet 50mg may be needed. Please consult your doctor.
Liver:SAFE IF PRESCRIBED
Bonglip Tablet 50mg is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Bonglip Tablet 50mg may not be needed in these patients. Please consult your doctor.However, Bonglip Tablet 50mg has not been studied in patients with severe hepatic impairment and is not recommended for use in such patients.
09Drug Tips
Bonglip Tablet 50mg should be taken at the same time every day since this helps you remember to take it.
It may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines or alcohol, or if you delay or miss a meal.
Always carry some sugary food or fruit juice with you in case you experience hypoglycemia symptoms such as cold sweats, cool, pale skin, tremors, and anxiety.
Be careful while driving or operating machinery until you know how Bonglip Tablet 50mg affects you.
Inform your doctor if you notice joint pain or develop symptoms such as stomach pain, nausea, and/or vomiting.
You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with this medicine.
Monitor your blood sugar level regularly while taking this medicine.
References
Sources and references
Sitagliptin [Product Monograph]. Kirkland, Canada: Merck Canada Inc.; 2021. [Accessed 8 Oct. 2021] (online) Available from: View
Sitagliptin [Product Information]. [Accessed 8 Oct. 2021] (online) Available from: View
Sitagliptin [Package Insert]. Gangtok, Sikkim: Torrent Pharmaceuticals Ltd.; 2022. [Accessed 06 Aug. 2023]. (online) Available from: View
Sitagliptin [Prescribing Information]. Pennington, NJ: Zydus Pharmaceuticals (USA) Inc.; 2025. [Accessed 09 Apr. 2025]. (online) Available from: View
